Jane Street’s Windtree Therapeutics WINT Stock Holding History

Jane Street’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14,599	Closed	-$7.53K	–	11895
2025 Q2	$7.53K	Buy	+14,599	New	+$12.9K	﹤0.01%	9416
2021 Q3	–	Sell	-1	Closed	-$73K	–	10832
2021 Q2	$73K	Buy	+1	New	+$97.3K	﹤0.01%	9397

Jane Street's WINT Position: Q3 2025 in Review

Jane Street sold out of Windtree Therapeutics (WINT) in Q3 2025, closing a stake of 14,599 shares — an estimated $7.53K sold.

Jane Street first reported a position in WINT in Q2 2021 and held it in 2 quarters. The position peaked at $73K in Q2 2021. 0 funds tracked by Wall St. Rank hold WINT as of Q3 2025.

Jane Street reported no remaining Windtree Therapeutics position as of Q3 2025 after selling out during the quarter.
Jane Street sold 14,599 Windtree Therapeutics shares in Q3 2025, an estimated $7.53K.
Jane Street first reported a position in Windtree Therapeutics in Q2 2021 and held it in 2 quarters.
Jane Street's Windtree Therapeutics position peaked at $73K in Q2 2021.
0 funds tracked by Wall St. Rank held Windtree Therapeutics as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.